PANews reported on December 2nd that, according to Cryptopolitan, two former executives of Gryphon Digital Mining have been appointed as heads of a newly formed cryptocurrency asset management division, a joint venture between Trump Media and Crypto.com. According to Yorkville Acquisition Corp., these appointments will take effect upon completion of the business merger, which is expected to close in the first quarter of 2026. Following the merger, Steve Gutterman will become CEO, and Sim Salzman will become CFO. They previously oversaw Gryphon's restructuring, regulatory reporting, and capital markets transactions, and have held executive positions at E*TRADE, American Bitcoin, and Marathon Digital. The new entity was formed through a merger with the businesses of Trump Media Technology Group and Crypto.com, with the aim of acquiring and operating CRO as the preferred asset for the entity's long-term reserves. In September, the two companies announced the initial acquisition of 684.4 million CRO tokens at approximately $0.153 per token, for a total initial transaction value of approximately $105 million, paid in cash and stock.PANews reported on December 2nd that, according to Cryptopolitan, two former executives of Gryphon Digital Mining have been appointed as heads of a newly formed cryptocurrency asset management division, a joint venture between Trump Media and Crypto.com. According to Yorkville Acquisition Corp., these appointments will take effect upon completion of the business merger, which is expected to close in the first quarter of 2026. Following the merger, Steve Gutterman will become CEO, and Sim Salzman will become CFO. They previously oversaw Gryphon's restructuring, regulatory reporting, and capital markets transactions, and have held executive positions at E*TRADE, American Bitcoin, and Marathon Digital. The new entity was formed through a merger with the businesses of Trump Media Technology Group and Crypto.com, with the aim of acquiring and operating CRO as the preferred asset for the entity's long-term reserves. In September, the two companies announced the initial acquisition of 684.4 million CRO tokens at approximately $0.153 per token, for a total initial transaction value of approximately $105 million, paid in cash and stock.
A former Gryphon executive will head the crypto asset company jointly established by Trump Media and Crypto.com.
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.
PANews reported on December 2nd that, according to Cryptopolitan, two former executives of Gryphon Digital Mining have been appointed as heads of a newly formed cryptocurrency asset management division, a joint venture between Trump Media and Crypto.com. According to Yorkville Acquisition Corp., these appointments will take effect upon completion of the business merger, which is expected to close in the first quarter of 2026. Following the merger, Steve Gutterman will become CEO, and Sim Salzman will become CFO. They previously oversaw Gryphon's restructuring, regulatory reporting, and capital markets transactions, and have held executive positions at E*TRADE, American Bitcoin, and Marathon Digital.
The new entity was formed through a merger with the businesses of Trump Media Technology Group and Crypto.com, with the aim of acquiring and operating CRO as the preferred asset for the entity's long-term reserves. In September, the two companies announced the initial acquisition of 684.4 million CRO tokens at approximately $0.153 per token, for a total initial transaction value of approximately $105 million, paid in cash and stock.
Opportunità di mercato
Valore OFFICIAL TRUMP (TRUMP)
$3.357
$3.357$3.357
USD
Grafico dei prezzi in tempo reale di OFFICIAL TRUMP (TRUMP)
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.
Potrebbe anche piacerti
CME Group to launch options on XRP and SOL futures
The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval. CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval. The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction. The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team. ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Condividi
BitcoinEthereumNews2025/09/18 00:56
Why YouCam AI API is the Secret Weapon for E-Commerce Startups
The New Standard of Personalized Shopping In an era where digital engagement dictates market share, the transition from “browsing” to “buying” depends on confidence
Condividi
Techbullion2026/03/25 14:34
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution
The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Condividi
BitcoinEthereumNews2025/09/18 05:26
